The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| SIBN | +7.46% | -29.28% | -6.69% | -26% |
| S&P | +19.89% | +109.18% | +15.89% | +143% |
SI-BONE, Inc. engages in the provision of implantable devices used in the surgical treatment of the sacropelvic anatomy. It offers a proprietary minimally invasive surgical implant system, called iFuse, used to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that often causes severe lower back pain. The company was founded by Mark A. Reiley and Jeffrey W. Dunn on March 2008 and is headquartered in Santa Clara, CA.
| Q2 2025 | YOY Change | |
|---|---|---|
| Revenue | $48.63M | 21.7% |
| Gross Profit | $38.81M | 22.9% |
| Gross Margin | 79.80% | 0.8% |
| Market Cap | $802.00M | 50.5% |
| Market Cap / Employee | $2.30M | 0.0% |
| Employees | 349 | 1.5% |
| Net Income | -$6.15M | 31.2% |
| EBITDA | -$5.64M | 38.0% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q2 2025 | YOY Change | |
|---|---|---|
| Net Cash | $34.15M | 33.5% |
| Accounts Receivable | $24.37M | -1.7% |
| Inventory | 34.2 | 47.4% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $35.83M | -3.3% |
| Short Term Debt | $1.11M | -62.7% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -10.45% | 7.4% |
| Return On Invested Capital | -26.92% | 4.8% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$1.93M | 79.6% |
| Operating Free Cash Flow | $0.17M | 102.7% |
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | 3.54 | 3.55 | 3.54 | 4.78 | 48.97% |
| Price to Sales | 3.71 | 3.52 | 3.36 | 4.35 | 22.62% |
| Price to Tangible Book Value | 3.54 | 3.55 | 3.54 | 4.78 | 48.97% |
| Enterprise Value to EBITDA | -72.17 | -111.24 | -78.48 | -123.61 | 165.69% |
| Return on Equity | -22.1% | -18.4% | -16.0% | -14.2% | -40.59% |
| Total Debt | $40.18M | $37.48M | $37.15M | $36.93M | -7.67% |
SIBN earnings call for the period ending March 31, 2020.
SIBN earnings call for the period ending December 31, 2019.
SIBN earnings call for the period ending September 30, 2019.
SIBN earnings call for the period ending June 30, 2019.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
